Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET

被引：96

作者：

Arnaud, Lisette ^{[1
]}

Chen, She ^{[1
]}

Liu, Fei ^{[1
]}

Li, Bin ^{[1
]}

Khatoon, Sabiha ^{[1
]}

Grundke-Iqbal, Inge ^{[1
]}

Iqbal, Khalid ^{[1
]}

机构：

[1] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA

来源：

FEBS LETTERS | 2011年 / 585卷 / 17期

基金：

美国国家卫生研究院;

关键词：

Alzheimer disease; Asparaginyl endopeptidase; Ischemic stroke; PHAPII; Protein phosphatase-2A; Tauopathies; PROTEIN PHOSPHATASE 2A; ACTIVATING FACTOR-I; SET; DISEASE; IDENTIFICATION; LOCALIZATION; DEPHOSPHORYLATION; PHOSPHORYLATION; PURIFICATION; EXPRESSION;

D O I：

10.1016/j.febslet.2011.07.020

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Protein phosphatase-2A (PP2A) activity, which is compromised in Alzheimer disease brain, is regulated by two endogenous inhibitors, one of them being I-2(PP2A), a 277 amino acid long protein also known as SET. Here we report that both the amino terminal fragment (I-2NTF; aa 1-175) and the carboxy terminal fragment (I-2CTF; aa 176-277) of I-2PP2A inhibit PP2A by binding to its catalytic subunit PP2Ac and cause hyperphosphorylation of tau. The C-terminal acidic region in I-2CTF and Val 92 in I-2NTF are essential for their association with PP2Ac and inhibition of the phosphatase activity. Structured summary of protein interactions: I2PP2A physically interacts with PP2A-C by anti tag coimmunoprecipitation (view interaction 1, 2) I2PP2A physically interacts with PP2A-C by pull down (view interaction 1, 2) PP2A-A physically interacts with PP2A-B and PP2A-C by pull down (view interaction) (C) 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.

引用

页码：2653 / 2659

页数：7

共 36 条

[1] IDENTIFICATION OF IN-VIVO PHOSPHORYLATION SITES OF SET, A NUCLEAR PHOSPHOPROTEIN ENCODED BY THE TRANSLOCATION BREAKPOINT IN ACUTE UNDIFFERENTIATED LEUKEMIA [J].

ADACHI, Y ;

PAVLAKIS, GN ;

COPELAND, TD .

FEBS LETTERS, 1994, 340 (03) :231-235

[2]

ADACHI Y, 1994, J BIOL CHEM, V269, P2258

[3] Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity [J].

Alonso, Alejandra Del C. ;

Li, Bin ;

Grundke-Iqbal, Inge ;

Iqbal, Khalid .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) :8864-8869

[4] Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses [J].

Blalock, EM ;

Geddes, JW ;

Chen, KC ;

Porter, NM ;

Markesbery, WR ;

Landfield, PW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (07) :2173-2178

[5] PAT1 induces cell death signal and SET mislocalization into the cytoplasm by increasing APP/APLP2 at the cell surface [J].

Briand, Stephanie ;

Facchinetti, Patricia ;

Clamagirand, Christine ;

Madeira, Alexandra ;

Pommet, Jean-Michel ;

Pimplikar, Sanjay W. ;

Allinquant, Bernadette .

NEUROBIOLOGY OF AGING, 2011, 32 (06) :1099-1113

[6] Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine [J].

Chohan, Muhammad Omar ;

Khatoon, Sabiha ;

Iqbal, Inge-Grundke ;

Iqbal, Khalid .

FEBS LETTERS, 2006, 580 (16) :3973-3979

[7] Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor [J].

Fan, ZS ;

Beresford, PJ ;

Oh, DY ;

Zhang, D ;

Lieberman, J .

CELL, 2003, 112 (05) :659-672

[8]

GOEDERT M, 1995, J NEUROCHEM, V65, P2804

[9] Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5 [J].

Gong, CX ;

Liu, F ;

Wu, GX ;

Rossie, S ;

Wegiel, J ;

Li, L ;

Grundke-Iqbal, I ;

Iqbal, K .

JOURNAL OF NEUROCHEMISTRY, 2004, 88 (02) :298-310

[10] PHOSPHOPROTEIN PHOSPHATASE-ACTIVITIES IN ALZHEIMER-DISEASE BRAIN [J].

GONG, CX ;

SINGH, TJ ;

GRUNDKEIQBAL, I ;

IQBAL, K .

JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :921-927

← 1 2 3 4 →